Clinical Trial Update: Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety of rapamycin given before and during radiotherapy for rectum cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectum Cancer

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Rectum Cancer | Phase 1, Phase 2 | Status: COMPLETED